NCT00196872View on ClinicalTrials.gov

A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)

PHASE3CompletedINTERVENTIONAL

Enrollment

3,000

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Breast Cancer

Interventions

DRUG

Epirubicine

Epirbubicne is given

DRUG

Cyclophosphamide

Cyclophosphamide is given

DRUG

Taxol

Taxol is given

DRUG

Xeloda

Xeloda is given

DRUG

Ibandronat

Ibandronat is given

Trial Locations (1)

65929

Städtische Kliniken Frankfurt a.M.-Höchst, Frankfurt

All Listed Sponsors

lead

GBG Forschungs GmbH

OTHER

NCT00196872 - A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) | Biotech Hunter | Biotech Hunter